SEATTLE, Wash., May 04, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Lexaria Bioscience Corp.’s (CSE:LXX) (LXX.CN) (CNSX:LXX) (OTCQX:LXRP) DehydraTECH™ platform which enables edibles manufacturers to increase bioavailability, improve flavor profiles, and expedite the onset of cannabinoid effects across a wide range of products. Investors may want to take note of the stock since the company’s growing number of licensees represents an attractive way to build exposure to edibles through royalty-based licensing agreements.
The cannabis industry is projected to reach $50 billion by 2026, according to Cowen & Co., driven by the legalization of adult-use cannabis across many states. With adult-use on the rise, consumer preferences are quickly shifting from smoking cannabis flower to consuming edible products that are better-tasting and faster-acting. Investors may want to consider building exposure to the edibles space to capitalize on these trends.
Innovative DehydraTECH™ Platform
Lexaria’s patented DehydraTECH™ technology is designed to increase the bioavailability, improve the flavors, and rapidity of onset of cannabinoids across a wide range of products, from capsules to edibles to beverages. Earlier this year, the company secured key patents on the technology covering these use cases, as well as other innovative areas of application, such as for the delivery of NSAIDS, nicotine, and vitamins.
The company is monetizing the DehydraTECH™ platform through partnerships across many different vertical markets. In exchange for the right to use the technology, the company often receives a lump sum payment and royalties on revenue generated from products developed using the technology platform. These agreements provide shareholders with near-term lump sum revenue and predictable revenue streams over the long-term.
Management has signed a number of licensing agreements since DehydraTECH™’s launch earlier this year. For example, the company has been working with Nuka Enterprises to develop chocolates and other edibles using the technology for the past two years, as well as GP Holdings LLC in developing cannabis-infused beverages. These represents multi-billion dollars markets that are rapidly growing throughout the world.
New License Agreement
Lexaria recently signed a new license agreement with Nuka Enterprises LLC, which makes 1906 brand cannabis chocolates and other edibles products. After utilizing the DehydraTECH™ platform for nearly two years, the company has risen to become one of Colorado’s top cannabis chocolate brands available in over 150 locations. The decision to renew its license to use DehydraTECH™ represents a strong vote of confidence in the technology.
“1906 products are a unique combination of nature and science, bringing together natural plant medicines delivered in delicious form factors, such as chocolate, with advanced technologies that make them safe, predictable, fast-acting, and efficacious,” said Nuke Enterprises CEO Peter Barsooom. “We’ve worked closely with Lexaria through 1906’s development and launch phases to create the best possible products that taste great, reduce onset times, and deliver amazing experiences. Fast-acting edibles are the wave of the future - it’s what consumers want - and we are at the forefront of bringing innovations to address customer needs.”
Under the new ten year semi-exclusive agreement, Nuka Enterprises will leverage DehydraTECH™ in its U.S.-based products with a focus on recreational states like Colorado, Nevada, California, New Jersey, and Massachusetts. The company also has acquired an option to expand its products and brand to Canada, including through the use of Lexaria’s existing chocolate and confections contract manufacturer licensee, Cannfections Group Inc.
Looking Ahead
Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) represents a compelling investment opportunity in the burgeoning cannabis industry. With its DehydraTECH™ platform gaining traction, the company is quickly building a steady stream of recurring revenue that could unlock significant value for shareholders over time. Investors may want to take a look at the stock sooner rather than later to capitalize on these dynamics.
For more information, visit the company’s website or download their investor presentation.
Please follow the link to read the full article: http://www.cannabisfn.com/lexaria-solidifies-presence-edibles-market-new-agreement/
About CFN Media
CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Contact:
Frank Lane
206-369-7050
Flane@cannabisfn.com